Definiumtherapeutics
Director, Tax
Hybrid. Posted 8 days ago
The role
You will develop and execute tax strategy as the company transitions to a commercial-stage company. You will oversee tax accounting, planning, and compliance while building infrastructure for commercial operations.
What you will do
- Lead tax strategy and planning including financings, equity compensation, and strategic transactions
- Own ASC 740 tax accounting for SEC reporting and audits
- Oversee federal, state, local, and international compliance performed by external providers
- Lead tax readiness for commercialization including state, local, sales, use, franchise, and nexus considerations
- Manage tax attributes and credits including Section 382, NOL preservation, and R&D credit studies
- Support business development, licensing, collaboration transactions, transfer pricing, and legal entity planning
- Serve as principal liaison to external tax advisors
- Partner with various departments to build scalable tax processes, policies, and documentation
Required qualifications
- Minimum bachelor's degree in accounting, Finance, Tax, or a related field
- CPA certification
- Minimum 10 years of progressive tax experience
- Strong knowledge of ASC 740 and U.S. corporate taxation
- Experience supporting public company reporting and managing external tax service providers
- Strong project management, organizational, and communication skills
Nice to have
- Master's in Taxation (MST) or advanced tax credential
- Big Four or national public accounting experience
- Biotech, pharmaceutical, life sciences, or healthcare industry experience
- Experience supporting organizations transitioning from development-stage to commercial operations
- Experience with Section 382, NOL planning, R&D credits, multi-state taxation, equity compensation, and capital markets transactions
Benefits
- health insurance
- 401(k) with company match
- flexible time off
- additional wellness benefits and perks
About the company
Definium Therapeutics is a late-stage clinical biopharmaceutical company. It is headquartered in New York and trades on Nasdaq under the symbol DFTX.